Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 5/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11142985 | 0.84 | MAPT (0.67) | MAPTALDH1A1POLBKMT2APKM | |
| SCHEMBL14962804 | 0.84 | HPGD (0.81) | MAPTALDH1A1KMT2AMEN1HPGD | |
| SCHEMBL10876285 | 0.84 | MEN1 (0.58) | MAPTALDH1A1POLBKMT2AMEN1 | |
| SCHEMBL5343120 | 0.84 | KMT2A (0.64) | MAPTALDH1A1POLBKMT2APKM | |
| SCHEMBL9018657 | 0.83 | MEN1 (0.71) | MAPTALDH1A1POLBKMT2AMEN1 | |
| SCHEMBL7004973 | 0.82 | MEN1 (0.71) | MAPTALDH1A1POLBKMT2AMEN1 | |
| SCHEMBL1706183 | 0.81 | KMT2A (0.65) | MAPTALDH1A1POLBKMT2APKM | |
| SCHEMBL11877123 | 0.81 | HPGD (0.60) | MAPTALDH1A1KMT2APKMMEN1 | |
| SCHEMBL27325188 | 0.80 | KMT2A (0.56) | MAPTALDH1A1POLBKMT2APKM | |
| SCHEMBL23811 | 0.80 | KMT2A (0.62) | MAPTALDH1A1POLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113527128-B | Method for continuously synthesizing 2-methoxy-4-nitroacetanilide | 淮阴工学院 | 2024-03-26 | — | — | CN | claimed |
| CN-116041202-A | Method for synthesizing 2-methoxy-4-nitroacetanilide by continuous flow reactor | 浙江万丰化工股份有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-113185418-B | Continuous flow production process of red base B | 山东师范大学实验厂有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-113185417-B | Red base B separation process | 山东师范大学实验厂有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-113527128-A | Method for continuously synthesizing 2-methoxy-4-nitroacetanilide | 淮阴工学院 | 2021-10-22 | — | — | CN | claimed |
| CN-113185418-A | Continuous flow production process of haematochrome B | 山东师范大学实验厂 | 2021-07-30 | — | — | CN | claimed |
| CN-113185417-A | Red base B separation process | 山东师范大学实验厂 | 2021-07-30 | — | — | CN | claimed |
| CN-113527128-B | Method for continuously synthesizing 2-methoxy-4-nitroacetanilide | 淮阴工学院 | 2024-03-26 | — | — | CN | disclosed |
| CN-113527128-B | Method for continuously synthesizing 2-methoxy-4-nitroacetanilide | 淮阴工学院 | 2024-03-26 | — | — | CN | disclosed |
| CN-113527128-B | Method for continuously synthesizing 2-methoxy-4-nitroacetanilide | 淮阴工学院 | 2024-03-26 | — | — | CN | disclosed |
| CN-116041202-A | Method for synthesizing 2-methoxy-4-nitroacetanilide by continuous flow reactor | 浙江万丰化工股份有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-116041202-A | Method for synthesizing 2-methoxy-4-nitroacetanilide by continuous flow reactor | 浙江万丰化工股份有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-116041202-A | Method for synthesizing 2-methoxy-4-nitroacetanilide by continuous flow reactor | 浙江万丰化工股份有限公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-1775298-A1 | THIENOPYRAZOLE DERIVATIVE HAVING PDE7 INHIBITORY ACTIVITY | Daiichi Asubio Pharma Co., Ltd. (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-20030036653-A1 | Diaminopyridine-containing thiourea inhibitors of herpes viruses | AMERICAN HOME PRODUCTS CORPORATION | 2003-02-20 | — | — | US | disclosed |
| US-20020026055-A1 | Aminopyridine-containing thiourea inhibitors of herpes viruses | AMERICAN HOME PRODUCTS CORPORATION | 2002-02-28 | — | — | US | disclosed |
| US-20010039348-A1 | Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-11-08 | — | — | US | disclosed |
| US-4472582-A | 3,5-Disubstituted-4'-(9-acridinylamino)-methane-sulfon-m-anisidide compounds having antitumor properties | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1984-09-18 | — | — | US | disclosed |
| EP-0025705-B1 | COMPOUNDS HAVING ANTITUMOUR PROPERTIES, PROCESS FOR THEIR PREPARATION, THESE COMPOUNDS FOR USE AS ANTITUMOUR AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1983-06-22 | — | — | EP | disclosed |
| EP-0025705-A1 | Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1981-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030036653-A1 | Diaminopyridine-containing thiourea inhibitors of herpes viruses | HAVCR2, CCR6, CXCR6 | MAPT 3898/4885ALDH1A1 3447/4885POLB 1347/4885 |
| US-20010039348-A1 | Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group | CCR6, HAVCR2, BCOR | MAPT 3272/4885ALDH1A1 3620/4885POLB 847/4885 |
| US-20020026055-A1 | Aminopyridine-containing thiourea inhibitors of herpes viruses | TK1, TPMT, CXCR6 | MAPT 4129/4885ALDH1A1 3601/4885POLB 1683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.